Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Fallopian Tube Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 6Pancreatic Neoplasms 4Brenner Tumor 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Thymoma 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2HIV Infections 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Endometrial Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Anus Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Teratoma, Testicular 1Teratoma, Ovarian 1Teratoma 1Sertoli-Leydig Cell Tumor 1

Interventions

Gemcitabine 6Cisplatin 3Capecitabine 3Platinum 21,2-diaminocyclohexaneplatinum II citrate 2spartalizumab 1pembrolizumab 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Ondansetron 1Lymph Node Excision 1Dexamethasone 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gallbladder Neoplasms × Taxes × Clear all
NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

SWOG Cancer Research Network

Phase 3 Completed
452 enrolled 17 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡